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-l-Arabinofuranosidases from glycoside hydrolase family 51 use a stereo-
chemically retaining hydrolytic mechanism to liberate nonreducing terminal
-l-arabinofuranose residues from plant polysaccharides such as arabinoxylan
and arabinan. To date, more than ten fungal GH51 -l-arabinofuranosidases
have been functionally characterized, yet no structure of a fungal GH51 enzyme
has been solved. In contrast, seven bacterial GH51 enzyme structures, with low
sequence similarity to the fungal GH51 enzymes, have been determined. Here,
the crystallization and structural characterization of MgGH51, an industrially
relevant GH51 -l-arabinofuranosidase cloned from Meripilus giganteus, are
reported. Three crystal forms were grown in different crystallization conditions.
The unliganded structure was solved using sulfur SAD data collected from a
single crystal using the I23 in vacuo diffraction beamline at Diamond Light
Source. Crystal soaks with arabinose, 1,4-dideoxy-1,4-imino-l-arabinitol and
two cyclophellitol-derived arabinose mimics reveal a conserved catalytic site and
conformational itinerary between fungal and bacterial GH51 -l-arabino-
furanosidases.
1. Introduction
-l-Arabinofuranosidase activity is an important part of
catabolic pathways which facilitate the saccharification of
hemicellulosic and pectinaceous polysaccharides such as
xyloglucan (Hemsworth et al., 2016), arabinoxylan (Rogowski
et al., 2015) and arabinan (Matsuo et al., 2000). These potential
substrates contain a variety of arabinosyl linkage types,
including (1,2) and (1,3) linkages to xylopyranose
(Izydorczyk & Biliaderis, 1994; York et al., 1996), and (1,2),
(1,3) and (1,5) linkages to arabinofuranose (Wefers et al.,
2018). Exo--l-arabinofuranosidases, such as those found in
glycoside hydrolase (GH) families 43, 51, 54 and 62 (Lombard
et al., 2014), often display a broad substrate specificity, facil-
itating the degradation of multiple polysaccharide substrates
(Beylot et al., 2001; Sakamoto et al., 2013).
The saccharification of arabinoxylan, a major component of
non-starch biomass derived from grasses (McNeil et al., 1975),
by fungi can be limited by incomplete side-chain removal,
reducing the overall efficiency with which the biomass can be
broken down and converted (Gilbert, 2010). The activities of
both GH51 and GH54 -l-arabinofuranosidases are known to
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be hindered by steric crowding around the -l-arabino-
furanose residue (Koutaniemi & Tenkanen, 2016). Specifically,
an industrial fungal GH51 -l-arabinofuranosidase from
Meripilus giganteus (MgGH51) requires a synergistic GH43
enzyme from Humicola insolens (AXHd3) to completely
debranch arabinoxylan (Sørensen et al., 2006). MgGH51 effi-
ciently removes -l-arabinofuranose residues from the 2 or 3
positions of monosubstituted xylose residues, while AXHd3
cleaves -l-arabinofuranose residues from xylose residues
which are substituted at both the C2 and C3 hydroxyl groups.
Structural studies of AXHd3 have shown that it contains a
second shallow pocket adjacent to the active-site cleft which
accommodates the additional C2-linked -l-arabinofuranose
residue (McKee et al., 2012), an active-site structure distinct
from those of Bacillus subtilis AXH-m2,3 (Vandermarliere et
al., 2009) and Cellvibrio japonicus Arb43A (Nurizzo et al.,
2002), which display similar activities.
The structure of theMgGH51 active site, and thus the basis
of its specificity and activity, remains unknown. To date, a
variety of GH51 enzymes displaying similar properties to
MgGH51 have been identified, including enzymes from
Aspergillus sp. (Koseki et al., 2003; Bauer et al., 2006; Kouta-
niemi & Tenkanen, 2016), Penicillium chrysogenum (Saka-
moto & Kawasaki, 2003) and Talaromyces purpureogenus
(Fritz et al., 2008), suggesting that the niche of GH51 is
conserved across the fungal kingdom, yet no structure of a
fungal GH51 -l-arabinofuranosidase has been solved. Owing
to the low sequence similarity between bacterial and fungal
GH51 enzymes, it is not possible to generate a reliable
sequence alignment or homology model for any characterized
fungal GH51 enzyme, thus limiting our understanding of this
enzyme class.
Structural investigations of the catalytic mechanism of
bacterial GH51 -l-arabinofuranosidases have primarily
leveraged site-directed mutagenesis. A complex between an
acid/base mutant of AbfA from Geobacillus stearothermo-
philus and two substrates, 4-nitrophenyl -l-arabinofurano-
side and Ara-(1,3)-Xyl, revealed a 4E ring conformation in
the Michaelis complex, priming the substrate for nucleophilic
attack (Hövel et al., 2003). Similar mutagenesis and crystallo-
graphic analysis of an -l-arabinofuranosidases from
Clostridium thermocellum (CtAraf51A) revealed that loose
specificity towards arabinan and arabinoxylan was facilitated
by a +1 subsite which interacted primarily through hydro-
phobic stacking interactions and not more geometrically
constrained hydrogen-bonding interactions (Taylor et al.,
2006).
Chemical biology tools provide a more facile approach to
the study of fungal enzymes, which require considerably more
work to genetically engineer. For example, reversible inhibi-
tors such as 1,4-dideoxy-1,4-imino-l-arabinitol (AraDNJ)
have been applied to the study of GH62 -l-arabino-
furanosidases, binding in a Michaelis complex-like 4E
conformation and facilitating the identification of the catalytic
water molecule of an inverting -l-arabinofuranosidase
(Moroz et al., 2018). Irreversible inhibitors, such as -l-
arabinocyclophellitol aziridine (-l-AraAZI) and -l-arabino-
cyclophellitol cyclic sulfate (-l-AraCS), have recently been
shown to label the active sites of both GH51 and GH54
-l-arabinofuranosidases, often mimicking the expected 2E
conformation of the glycosyl-enzyme intermediate (McGregor
et al., 2020). Using this chemical biology approach, we aimed
to determine the structure of a fungal GH51 enzyme, identify
its key catalytic residues and compare the catalytic sites and
mechanisms of fungal and bacterial GH51 enzymes. To this
end, we have crystallized MgGH51 and solved its structure in
the unliganded state and in complex with l-arabinose,
AraDNJ, -l-AraAZI and -l-AraCS (Fig. 1). Owing to the
challenges faced in solving the phase problem for this enzyme
(see below), the I23 in vacuo beamline (Wagner et al., 2016)
was leveraged to solve the structure using sulfur SAD (Rose et
al., 2015), a technique that has been made tremendously more
accessible by this new beamline.
2. Materials and methods
Reagents were purchased from Sigma Millipore unless
otherwise stated. The synthesis of AraDNJ was carried out
according to literature procedures (Jones et al., 1985; Naleway
et al., 1988), as were the syntheses of the cyclophellitol-derived
inhibitors (McGregor et al., 2020).
2.1. Enzyme production and purification
Culture broth containing secreted MgGH51 (Table 1) was
produced as described by Sørensen et al. (2006). Filtrated
broth was applied onto a Sephadex G-25 medium
(GE Healthcare, Piscataway, New Jersey, USA) column
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Figure 1
Structures of the ligands used in this study.
equilibrated with 25 mM sodium acetate pH 4 and applied
onto a SOURCE 15S column (GE Healthcare, Piscataway,
New Jersey, USA) equilibrated with the same buffer. Bound
proteins were eluted with a linear gradient from 0 to 1000 mM
sodium chloride over ten column volumes. Fractions were
collected and analysed by SDS–PAGE. MgGH51-bearing
fractions were pooled and the pH was adjusted to 5.5.
2.2. Substrate-hydrolysis kinetic measurements
32--l-Arabinofuranosyl-xylobiose (AX2), (1,5)-linked
arabinotriose (A3) and (1,5)-linked arabinopentaose (A5)
were purchased fromMegazyme International (Bray, Ireland).
Hydrolytic kinetics were measured essentially as described in
McGregor et al. (2017). Briefly, reactions were set up at 40C
in 50 mM sodium acetate buffer pH 4 containing 5 ng ml1
MgGH51 and between 0.02 and 2.5 mM substrate. Reactions
were stopped by the addition of ammonium hydroxide to give
a final pH of 10.1 and free l-arabinose was quantified by the
separation of 5 ml of the resulting solution on a CarboPac
PA20 column at a flow rate of 0.5 ml min1. The separation
program was a 5 min isocratic flow of 50 mM sodium hydro-
xide, followed by a 5 min gradient to 50 mM sodium hydro-
xide, 100 mM sodium acetate, followed by a 3 min
equilibration under the initial conditions. l-Arabinose was
quantified relative to a calibration curve ranging from 2 to
250 mM.
2.3. Crystallization and complex preparation
Crystallization screening was carried out by sitting-drop
vapour diffusion. Droplets containing 150 nl reservoir solution
(RS) and either 150 or 300 nl protein solution (PS) were
dispensed into 96-well MRC 2-well crystallization microplates
(Swissci, Switzerland) and were equilibrated against 50 ml RS.
Duplicate plates were stored at 6 or 20C. MgGH51 crystals
grew under two different conditions (Table 2). Trays set up at
20C with 10 mg ml1 MgGH51 in 10 mM sodium acetate
buffer pH 5.5 with 100 mM NaCl yielded radial plate clusters
(type 1) with 2:1 PS:RS, where the RS consisted of 0.1 MMES
buffer pH 6, 0.2 M NaCl, 20% PEG 6000. A mixture of
isolated rectangular and square plates with rounded edges
(type 2) and rectangular prisms (type 3) grew from 2:1 PS:RS
at 20C, where the RS consisted of 2.2 M ammonium sulfate,
20% glycerol. Optimized type 1 crystals (Supplementary Fig.
S1a) grew from 20% PEG 3350, 0.1 M bis-Tris–HCl pH 6.5,
0.2 M sodium nitrate in 1–3 days and optimized type 2 crystals
(Supplementary Fig. S1b) grew from 2.4 M ammonium sulfate,
0.1 M sodium acetate pH 6.0, 20% glycerol in 2–7 days. High-
quality type 3 crystals (Supplementary Fig. S1c) grew more
commonly from 1.8 M ammonium sulfate, 0.1 M sodium
acetate pH 5.0–6.0, 35% glycerol in 5–14 days. Mixtures of
types 2 and 3 were rare; the growth of type 3 crystals appeared
to correlate with a lack of type 2 crystals.
Crystals were cryocooled in liquid nitrogen without addi-
tional cryoprotection. All complexes were generated from
type 1 crystals owing to competition for active-site binding
from glycerol and the occlusion of the active site by a neigh-
bouring molecule in type 2 and type 3 crystals. To generate the
l-arabinose and AraDNJ complexes, crystals were soaked in
RS containing 100 mM l-arabinose or 10 mMAraDNJ for 15–
30 min prior to cryocooling. To generate complexes with
cyclophellitol derivatives, 200 nl of 1 mM inhibitor (approxi-
mately one equivalent) was added directly to a 1500 nl crystal-
containing droplet. This was left to stand at room temperature
for 1 h prior to crystal cryocooling. Bromide-soaked crystals
were prepared following literature methods (Pike et al., 2016).
Briefly, type 1 and type 2 crystals were soaked in reservoir
solution prepared with 1M sodium bromide for 2–10 min
prior to cryocooling. Oligosaccharide soaks were also
performed with 10 mM xylopentaose or 10 mM cellohexaose
for 1 h prior to cryocooling.
2.4. Data collection and processing
All data were collected and processed at Diamond Light
Source (DLS), Harwell, UK. Initial native data sets for type 1
and type 2 crystals were collected on beamline I03 at a
wavelength of 0.9763 Å to 1.30 and 1.33 Å resolution,
respectively (Table 3). Three bromine SAD data sets were
collected to 1.8–1.9 Å resolution from separate sodium
bromide-soaked type 1 crystals (type 2 crystals did not tolerate
NaBr soaking) on beamline I04-1 at a wavelength of 0.9159 Å
(data not shown). Five sulfur SAD data sets were collected to
1.8 Å resolution (2-limited) from a single type 3 crystal at 
angles ranging from 0 to 25 using a wavelength of 2.75 Å
on beamline I23 (Table 3). Two high-resolution data sets were
collected to 1.2 Å resolution (crystal-limited) from a single
type 3 crystal at  angles of 0 and 20 using a wavelength of
1.375 Å on beamline I23. Single data sets were collected from
arabinose-, -l-AraAZI- and -l-AraCS-soaked type 1 crys-
tals at a wavelength of 0.9119 Å on beamline I04-1 (Table 3).
Three data sets were collected from two AraDNJ-soaked type
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Table 1
Macromolecule-production information.
Source organism Meripilus giganteus
Expression host Aspergillus oryzae
Complete amino-acid sequence
























1 crystals at a wavelength of 0.9795 Å on beamline I04 and
were merged (Table 3). Unless otherwise indicated, the data
sets were processed using the xia2 pipeline (Winter et al.,
2013) at DLS with DIALS (Winter et al., 2018). All other
calculations were carried out using CCP4 (Winn et al., 2011)
and figures were prepared using PyMOL (Schrödinger).
2.5. Structure solution and refinement
Using the native data sets collected from type 1 and type 2
crystals, attempts were made to solve the structure of
MgGH51 by molecular replacement. The type 1 data set was
indexed in space group P212121 and the type 2 data set was
indexed in space group C2221. Molecular replacement with
Phaser (McCoy et al., 2007) using native models and
CHAINSAW-modified (Stein, 2008) models generated from
chain A of Thermotoga maritimaGH51 (TmGH51; PDB entry
3ug3; Im et al., 2012) or Thermobacillus xylanilyticus GH51
(TxGH51; PDB entry 2vrk; Paës et al., 2008) failed to find any
significant solutions. Automated molecular replacement using
MrBUMP (Keegan & Winn, 2008) also failed to find any
solutions. Ab initio phasing with Fragon (Jenkins, 2018) was
also attempted, but failed, likely owing to the relatively small
fraction of the total scattering which could be accounted for by
fragments. Attempts were made to solve the bromine SAD
data sets using CRANK2 (Pannu et al., 2011), although a
research papers
Acta Cryst. (2020). D76, 1124–1133 McGregor et al.  GH51 -L-arabinofuranosidase 1127
Table 3
Data collection and processing.

















PDB code 6zpv 6zps 6zpw 6zpx 6zpy 6zpz 6zq0 6zq1
Diffraction source I23, DLS I23, DLS I03, DLS I03, DLS I04-1, DLS I04-1, DLS I04-1, DLS I04, DLS
Wavelength (Å) 1.3776 2.7552 0.9763 0.9763 0.9119 0.9119 0.9119 0.9795



















10† 10† 175 175 214 214 214 278
Rotation range per
image ()
0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
Total rotation range () 360 360 220 220 220 220 220 360
Exposure time per
image (s)
0.1 0.1 0.01 0.01 0.04 0.04 0.04 0.01
Space group P43212 P43212 C2221 P212121 P212121 P212121 P212121 P212121
















, ,  () 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90 90, 90, 90
Mosaicity () 0.10 0.10 0.16 0.40 0.31 0.27 0.14 0.23
































No. of unique reflections 285059 (13929) 74070 (4624) 265496 (12835) 188207 (9226) 176357 (8584) 79871 (3871) 110936 (5472) 85172 (4409)
Completeness (%) 100 (100) 84.4 (90.5)‡ 99.9 (98.0) 100 (99.7) 98.5 (97.3) 98.8 (98.5) 99.7 (99.7) 99.9 (99.4)
Multiplicity 33 (25.1) 70.2 (21.5) 8.0 (6.8) 7.8 (6.0) 7.9 (7.3) 7.5 (6.7) 7.7 (6.4) 34.5 (16.3)
hI/(I)i 27.2 (1.8)
[1.24 Å]§











CC1/2 1.000 (0.661) 0.999 (0.859) 0.999 (0.521) 0.998 (0.778) 0.996 (0.764) 0.997 (0.419) 0.999 (0.505) 0.999 (0.915)
Rr.i.m. 0.011 (0.430) 0.012 (0.142) 0.035 (0.727) 0.035 (0.422) 0.040 (0.374) 0.052 (0.694) 0.043 (0.731) 0.028 (0.281)
Overall B factor from
Wilson plot (Å2)
12.23 16.98 11.86 13.16 11.14 21.04 18.22 13.52
† Distance from the central axis of the cylindrical detector array. ‡ Completeness is low owing to the cylindrical shape of the detector and the long wavelength that was used. § Data
in the outer shell were cut using a CC1/2 limit of 0.5 or I/(I) > 1. The resolution at which I/(I) falls below 2.0 is provided in square brackets.
Table 2
Crystallization.
Method Sitting drop Sitting drop
Plate type Swissci 48-well MRC Maxi Swissci 48-well MRC Maxi
Temperature (K) 293 293
Protein concentration (mg ml1) 10 10
Buffer composition of protein solution 10 mM sodium acetate pH 5.5, 100 mM NaCl 10 mM sodium acetate pH 5.5, 100 mM NaCl
Composition of reservoir solution 20% PEG 3350, 0.1 M bis-Tris–HCl pH 6.5,
0.2 M NaNO3
1.8–2.4M (NH4)2SO4, 0.1M sodium acetate pH 5–6,
20–35% glycerol
Volume and ratio of drop 1.8 ml, 2:1 PS:RS 1.8 ml, 2:1 PS:RS
Volume of reservoir (ml) 100 100
substructure that provided sufficient phasing power could not
be determined.
Sulfur SAD phases were determined experimentally with
the CRANK2 pipeline using the first two of the five data sets
collected. The collection and merging of all of the data sets
from different  orientations was not necessary for phasing,
but improved the overall data completeness and quality for
model building and refinement. Substructure determination
identified a collection of 16 peaks which could be modelled as
S atoms with occupancy values of at least 0.1. These included
six peaks which could be modelled as S atoms with full
occupancies of 1 (giving anomalous map peak heights between
32 and 54) and ten weaker peaks which could be modelled
as partial occupancy S atoms (five of which gave anomalous
map peak heights of at least 10). Initial automated chain
tracing was performed using ARP/wARP. Following the
correction of two cis-proline residues and merging of the three
traced chains into one, the structure was refined by successive
rounds of manual model building and refinement using Coot
(Emsley et al., 2010) and REFMAC5 (Murshudov et al., 2011)
within the CCP4 suite (Winn et al., 2011). Sulfate molecules
and chloride ions were modelled with positions and occu-
pancies derived from anomalous refinement. Glycan struc-
tures, glycerol molecules and acetate molecules were modelled
manually, and water molecules were then added automatically
with manual adjustment. All other data sets were phased by
MOLREP (Vagin & Teplyakov, 2010) using the sulfur SAD
model prior to manual model adjustment and ligand model-
ling. Final refinement statistics for each structure can be found
in Table 4.
3. Results and discussion
3.1. Protein crystallization and structure determination
MgGH51 was very amenable to crystallization. Crystals of
MgGH51 reliably grew from two different conditions with
relatively broad ranges of reservoir-solution composition.
Three separate types of crystals were identified. One, which
was obtained when PEG was used as the major precipitant
(Supplementary Fig. S1a), grew optimally from bis-Tris pH 6.5
with 0.2 M sodium nitrate and diffracted to 1.3 Å resolution
in space group P212121. Similar conditions yielded crystals of
varying size and nucleation density with 0.2 M sodium sulfate,
sodium acetate, sodium formate, sodium malonate or sodium
tartrate in place of sodium nitrate and variable pH values from
6.5 to 8 with bis-Tris or Tris buffer. Crystals grew more rapidly
(in some cases overnight) with reservoir-solution PEG
concentrations of as high at 25%, but eventually fractured and
dissolved as the droplet continued to equilibrate against the
reservoir solution. Lower salt concentrations gave precipita-
tion, and salt concentrations above 0.4 M strongly inhibited
crystal nucleation. The major crystal pathologies were high
anisotropy, splitting and high mosaicity, necessitating careful
crystal selection and testing prior to diffraction.
Two other crystal types were observed in a narrower set of
conditions with reservoir solutions composed of ammonium
sulfate and glycerol with sodium acetate buffer. Type 2 crystals
grew as a mixture of square or rectangular plates with rounded
edges (Supplementary Fig. S1b). These grew optimally in
sodium acetate buffer pH 6.0 with 2.4 M ammonium sulfate
and 20% glycerol, regularly diffracting to1.3 Å resolution in
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Table 4
Structure solution and refinement.

















PDB code 6zpv 6zps 6zpw 6zpx 6zpy 6zpz 6zq0 6zq1
















Completeness (%) 100.0 (100.0) 84.5 (92.1) 99.9 (98.5) 99.9 (99.6) 98.4 (96.8) 99.4 (98.8) 99.9 (99.8) 99.9 (99.3)
No. of reflections, working set 270778 (19735) 70385 (5592) 252355 (18312) 178687 (13150) 167555 (12126) 75804 (5523) 105323 (7706) 80757 (5920)
No. of reflections, test set 14149 (1063) 3570 (270) 13118 (937) 9384 (629) 8652 (593) 3991 (276) 5515 (385) 4303 (264)
Final Rcryst 0.121 (0.227) 0.145 (0.160) 0.130 (0.266) 0.180 (0.340) 0.141 (0.293) 0.189 (0.304) 0.180 (0.321) 0.196 (0.297)
Final Rfree 0.144 (0.247) 0.178 (0.212) 0.151 (0.276) 0.217 (0.333) 0.179 (0.306) 0.225 (0.297) 0.206 (0.314) 0.216 (0.313)
Cruickshank DPI (Å) 0.024 0.090 0.030 0.049 0.041 0.101 0.070 0.100
No. of non-H atoms
Total 6281 5974 5807 5598 5827 5541 5608 5471
Protein 4915 4917 4857 4832 4849 4835 4824 4793
Ligand 269 278 221 123 153 137 133 132
Water 1097 762 725 643 824 568 650 545
Ion 0 17 1 1 1 1 1 1
R.m.s. deviations
Bond lengths (Å) 0.018 0.013 0.014 0.016 0.015 0.012 0.012 0.11
Angles () 2.1 1.8 1.9 1.9 1.8 1.7 1.8 1.7
Average B factors (Å2)
Protein 14.7 19.7 15.4 19.7 15.2 25.0 20.7 20.6
Ligand 30.2 34.3 28.7 31.3 25.8 37.6 31.7 32.0
Water 29.7 31.1 28.3 29.1 26.3 31.5 29.3 27.2
Ion — 41.7 15.4 33.4 18.24 31.4 31.3 26.1
Ramachandran plot
Most favoured (%) 97.9 98.4 98.1 97.9 98.4 97.3 98.2 97.6
Allowed (%) 100 100 100 100 100 100 100 100
space group C2221. Type 2 crystals displayed high anisotropy,
but were otherwise free from crystal pathology. Under lower
pH, higher glycerol and lower ammonium sulfate conditions,
type 2 crystals tended not to form, allowing the formation of
type 3 crystals (Supplementary Fig. S1c), which grew as
rectangular prisms of as large as 500  500  200 mm. Type 3
crystals consistently diffracted to 1.2 Å resolution in space
group P43212 with no crystal pathologies.
Initial attempts to solve the structure of MgGH51 using
data sets collected from type 1 and type 2 crystals by molecular
replacement were unsuccessful. We attribute this failure to the
poor sequence similarity between bacterial and fungal GH51
-l-arabinofuranosidases. Alignment of MgGH51 with its five
closest characterized bacterial homologues (E < 105) using
MUSCLE (Edgar, 2004) found 21–24% sequence identity
(Supplementary Table S1). Attempts to solve the structure of
MgGH51 using ab initio methods were also unsuccessful. We
attribute this failure to the relatively large size of the enzyme
monomer. The failure to detect the substructure using
bromine SAD was more surprising as all collected data sets
had an overall CCanom of >0.3. Subsequent analysis of the
anomalous map derived from the bromine SAD data sets
solved by molecular replacement with the sulfur SAD model
clearly showed 14 partial occupancy structured bromide ions
with anomalous map peak heights above 5, including three
with peak heights above 10. However, this diffuse set of
peaks was apparently insufficient to unambiguously determine
phases.
Thus, the structure of MgGH51 was solved by leveraging
the unique capabilities of beamline I23 at DLS to measure
anomalous signal at a wavelength of 2.75 Å in vacuo.
Although the anomalous signal was weak (overall CCanom =
0.13), it was robust across resolution bins and consistent in all
data sets. Combining two 360 data sets gave an anomalous
multiplicity of 15.2, an anomalous mean I/(I) of 0.82 and an
overall mean I/(I) of 32.4. This weak anomalous signal
proved sufficient for SHELXD to identify an unambiguous
collection of peaks with a CFOM of 49.6 using a resolution
cutoff of 2.78 Å. Subsequent refinement of these phases
followed by chain-tracing using ARP/wARP correctly identi-
fied the position of every amino-acid residue in the known
sequence (confirmed by N-terminal amino-acid sequencing;
data not shown). Initially, owing to the failure to identify two
cis-proline residues, three chains were traced, but these
proline residues were manually remodelled and the chains
were merged to complete the peptide-backbone structure. All
other collected data sets were then readily solved by mole-
cular replacement using this model.
3.2. The overall structure of MgGH51
The overall fold of the catalytic domain of MgGH51 is a
(/)8 domain with a 12-stranded -sandwich, typical of GH51
(Fig. 2). As in other GH51 enzymes, the N- and C-termini of
the sequence are found in the 12-stranded -sandwich domain,
but unlike bacterial GH51 enzymes MgGH51 has a 169-
residue ten-stranded -sandwich domain inserted following
the 36-residue N-terminal strand. Density for four units of the
N-glycan chitobiosyl ‘core’ was clearly visible, extending from
Asn145, Asn245, Asn421 and Asn487 in all structures.
Furthermore, for type 2 and type 3 crystals mannose residues
could be clearly modelled extending from the cores of two
glycans that were involved in crystal contacts.
Calculating the anomalous map for type 3 crystals revealed
a collection of structured peaks on the surface of the protein.
Comparable anomalous signal could be expected from either
sulfate molecules or chloride ions. A variety of factors,
including the distance between the anomalous peak and the
protein backbone, near-coincidence with a well defined water
molecule and the overall shape of the Fo  Fc map shape, led
us to interpret 17 of these peaks (with anomalous peak heights
of 5–10) as partial occupancy chloride ions. These chloride
ions could not be reliably modelled into any other data set
because of the lack of anomalous signal. Two acetate mole-
cules were identified in type 3 crystals based on their shape,
adjacency to cationic residues and lack of anomalous map
density.
All three crystal forms arose from distinct collections of
intermolecular interactions; however, both types 2 and 3 share
a crystal-packing interface which obscures the active-site cleft
(Supplementary Figs. S2b and S2c). This contrasts with type 1,
which packs with a fully solvent-exposed active-site cleft
(Supplementary Fig. S2a). Furthermore, a single molecule of
glycerol was identified in the putative active-site pocket of
MgGH51 in type 2 and type 3 crystals, while only water was
found in the active-site pocket of type 1 crystals, leading us to
perform ligand-binding studies using type 1 crystals.
research papers
Acta Cryst. (2020). D76, 1124–1133 McGregor et al.  GH51 -L-arabinofuranosidase 1129
Figure 2
Overview of the tertiary structure of MgGH51. The backbone of the
polypeptide chain (PDB entry 6zpv) is shown in cartoon representation
coloured from blue to red from the N-terminus to the C-terminus. The
solvent-accessible surface of the enzyme is shown as a transparent grey
surface. The observed high-mannose N-glycans, the side chains of key
active-site residues (Glu427, Glu349, Asn348, Tyr400 and Glu21) and a
glycerol molecule observed in the active-site pocket are shown as sticks
with black C atoms. 2Fo  Fc electron density contoured at 1.5 is shown
around the sticks.
3.3. Active-site structure and conformational itinerary of
MgGH51
A 1.27 Å resolution data set collected from a type 1
MgGH51 crystal soaked with -l-arabinose was solved with
clear density for a single molecule of -l-arabinose in the
active-site pocket (Fig. 3a). The positioning of the mono-
saccharide within the active site revealed key enzyme–product
interactions, including the hydrogen-bonding interactions
Tyr402–O5, Glu23–O3, Asn231–O3, Asn350–O2, Glu429–O2
and Glu351–O1. Glu429 was positioned directly below the
anomeric C atom, suggesting that it is the catalytic nucleo-
phile, while the Glu351–O1 interaction suggested that it is the
general acid/base. The bound arabinose is found with a 4T3
ring conformation, matching the reported conformation of
-l-arabinose bound in the active site of T. maritima GH51
(PDB entry 3ug4; Im et al., 2012).
AraDNJ is a well known reversible -l-arabinofurano-
sidase inhibitor. Often thought to mimic the oxocarbenium-
ion transition state of -l-arabinofuranoside cleavage
(Gloster et al., 2007), this inhibitor has recently been applied
in the understanding of the mechanism of GH62 -l-arabino-
furanosidases (Moroz et al., 2018), where it bound in a
Michaelis complex-like 4E conformation. Solving the structure
of MgGH51 in the presence of AraDNJ gave a 1.70 Å resol-
jution structure with clear density for AraDNJ in the active
site. Retaining the interactions observed between l-arabinose
and Tyr402, Glu23, Asn231 and Asn350, this structure
revealed an apparent binding of Glu429 across O2 and the
ring N atom, causing the ring to pucker into a 4E ring
conformation like that observed in GH62, not the E3 confor-
mation expected for the transition state.
Soaking MgGH51 crystals with stoichiometric -l-AraCS
or -l-AraAZI gave clear density for these two ligands bound
to Glu429, confirming its role as catalytic nucleophile (Fig. 3b).
Clear density was present for the primary amine or sulfate
group on C6 resulting from the ring-opening addition reaction
(Supplementary Fig. S3). While the steric bulk of the sulfate
group of -l-AraCS caused some rearrangement of the active
site, the addition of -l-AraAZI to Glu429, leaving a primary
amine in place of the sulfate, caused no apparent changes to
the protein structure relative to the unliganded enzyme,
suggesting that this structure is a good mimic for the natural
glycosyl-enzyme intermediate. In line with observations of the
complex between the same inhibitor and GsGH51, a bacterial
GH51 (McGregor et al., 2020), the furanose ring conformation
of the complex is 2E. MgGH51 follows a mechanism that runs
through the same conformational itinerary used by bacterial
GH51 -l-arabinofuranosidases. Thus, the conformational
itinerary of GH51 -l-arabinofuranosidases appears to be
conserved across kingdoms of life.
Interactions with the larger arabinoxylan substrate are of
particular interest because of the inability of MgGH51 to
hydrolyse l-arabinose residues from doubly substituted
d-xylose residues (Sørensen et al., 2006). For this enzyme, the
-l-arabinofuranose bound into the enzyme active site with
O1 pointing directly out of the active site into a narrow cleft.
We hypothesized that this cleft would bind xylooligosacchar-
ides. However, a soak with xylopentaose gave a type 1 crystal
structure with no apparent additional density in this active-
site-adjacent cleft (data not shown). Thus, the exact nature of
positive subsite interactions in fungal GH51 -l-arabinofur-
anosidases remains obscure, although active-site homology
provides a basis on which the nature of the interactions
between the enzyme and the xylan backbone may be inferred
(see below).
3.4. Homology to bacterial GH51 a-L-arabinofuranosidases
The most significant difference between MgGH51 and its
bacterial homologues is the presence of the additional
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Figure 3
Active site and conformational itinerary of MgGH51. (a) Active-site
arrangement of MgGH51 around -l-arabinofuranose. Active-site
residues interacting with -l-arabinofuranose (brown) are shown as blue
sticks. Apparent hydrogen-bonding interactions are shown as black
dashed lines. The interaction between the catalytic nucleophile and the
anomeric C atom is shown as an orange dashed line. Electron density is
shown as a mesh contoured at 1.5. (b) Overlay of the AraDNJ and -l-
AraAZI ligands within the MgGH51 active site. The active-site residues
and ligand from the -l-AraAZI complex are shown as grey sticks. The
active-site residues and ligand from the AraDNJ complex are shown as
cyan sticks. Apparent hydrogen-bonding interactions are shown as black
dashes.
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N-terminal -sandwich domain (Fig. 4a, blue). ADALI (Holm
& Laakso, 2016) search using this domain in isolation found
some structural similarity (r.m.s.d. of 2.7–2.8 Å, 14% sequence
identity) to CBM4 carbohydrate-binding modules, notably
PDB entries 2y6g and 3k4z, both of which are cellulose-
binding domains (von Schantz et al., 2012; Alahuhta et al.,
2010). Such domains are common components of biomass-
degrading enzymes (Boraston et al., 2004). However, this
CBM4-like domain is atypical, containing no apparent binding
cleft or aromatic binding platform. To look for signs of a
cellulose-binding site, crystals were soaked with 10 mM
cellohexaose, yielding a type 1 structure with no apparent
additional density (data not shown). Thus, it does not appear
that this domain has a xylan- or cellulose-binding site and it
does not appear to be an arabinofuranose-binding domain
akin to that found in A. kawachii GH54 (Miyanaga et al.,
2004). The purpose of this inserted domain remains unclear.
A simple sequence alignment between MgGH51 and
T. xylanilyticus GH51 (TxGH51; PDB entry 2vrq; Paës et al.,
2008), a structurally characterized bacterial homologue
(DALI Z-score of 35.2, r.m.s.d. of 2.5 Å), finds only 23%
sequence identity (Supplementary Table S1). However,
structural superposition ofMgGH51 onto TxGH51 using only
arabinofuranose, the general acid/base and the catalytic
nucleophile reveals significant overall structural homology
(Fig. 4b). The active sites of the two enzymes are nearly
identical, with absolute conservation of Tyr402 (Tyr242 in
TxGH51), Glu23 (Glu28 in TxGH51), Asn350 (Asn175 in
TxGH51), the Asn231 backbone (the Cys74 backbone in
TxGH51), Glu351 (Glu176 in TxGH51) and Glu429 (Glu298
in TxGH51). The only polar contact that is not conserved
between the two active sites is the interaction between Gln347
and O5 found only in TxGH51.
Structural alignment also reveals several areas of significant
restructuring around the active site. Below the active-site cleft
MgGH51 has two loop insertions, and above the active-site
cleft MgGH51 has two extended and significantly remodelled
loops (Fig. 4a, green). Together, these differences result in a
significantly more restricted active-site cleft. Superimposition
of the three xylose residues observed in PDB entry 2vrq onto
the model of MgGH51 suggests that the observed restruc-
turing does not interfere with xylan-chain binding but may
restrict access to the active site for bulkier, more highly
branched polysaccharides (Fig. 4c). Indeed, it has been
reported that MgGH51 is unable to cleave -l-arabino-
furanose residues from doubly substituted xylose residues
(Sørensen et al., 2006). The superimposition of xylose residues
from the structure of TxGH51 reveals that, with -l-arabino-
furanose extending from O3, there is no pocket which could
accommodate an -l-arabinofuranose residue extending from
O2 and that O2 is likely to form a hydrogen bond with Asp351
Figure 4
Homology of MgGH51 to TxGH51. (a) Loop representation of the structure of MgGH51 superimposed with TxGH51. For MgGH51, the catalytic
domain is shown in purple, the domain insertion in MgGH51 is shown in blue and the remodelled loops are shown in green. For TxGH51, the catalytic
domain is shown in tan and the remodelled loops (or sites of loop insertion) are shown in red. The ligand bound to TxGH51 is shown in ball-and-stick
representation. (b) Close-up view of the substrate-binding cleft of MgGH51 in surface representation with the same colouring as in (a). The
l-arabinofuranose observed bound toMgGH51 is shown in purple and the three xylose residues observed in the TxGH51 structure are superposed onto
the structure of MgGH51 to show the expected binding position of the xylan backbone. Phe354 and Phe441 are labelled and shown as sticks below the
transparent surface. (c) Close-up view of the superimposed active sites of TxGH51 and MgGH51. Both enzymes are shown as cartoon representations
with active-site residues and the bound l-arabinofuranose shown as ball-and-stick representations with the same colouring as in (a). Residue names are
from MgGH51 unless marked with a star. The TxGH51 residue homologous to Glu351 was engineered to be Gln in place of the wild-type Glu.
when unsubstituted (Fig. 4a). This superimposition also
suggests that interactions with the polysaccharide backbone in
the +1 subsite occur primarily through hydrophobic stacking
interactions with Phe354 and Phe441, a structural motif
analogous to that which is thought to be responsible for the
broad substrate specificity of CtAraf51A (Taylor et al., 2006).
Measurement of the hydrolytic kinetics of MgGH51 towards
the AX2 and A3 oligosaccharides confirmed the presence of
only a fourfold specificity for xylose over arabinose in the
positive subsites (Supplementary Fig. S4 and Table S1).
Owing to the relatively high degree of sequence similarity
among fungal GH51 enzymes (Supplementary Table S3),
reliable sequence alignments can be constructed for other
functionally characterized fungal GH51 enzymes (Supple-
mentary Fig. S5). In addition, the structure of MgGH51
presented here facilitates the construction of fungal GH51
homology models. To investigate a possible molecular ratio-
nale for the observation that some fungal GH51 enzymes,
notably A. niger GH51 (AnGH51), have detectable activity
towards l-arabinose on double-substituted xylose residues
(Koutaniemi & Tenkanen, 2016), we constructed a structural
model of AnGH51 using SWISS-MODEL with the MgGH51
template (Waterhouse et al., 2018; Supplementary Fig. S6).
Comparison of the modelled active-site cleft of AnGH51 with
the active-site cleft of MgGH51 shows a high degree of
conservation. However, Phe353 and Phe354 of MgGH51 are
replaced by methionine and leucine, while a loop below the
active site has been deleted. This has the cumulative effect of
significantly opening up the active site adjacent to O2 of the +1
xylose residue, possibly allowing a strained, but productive,
interaction. We believe that this combination of mutations and
loop deletion is likely to be responsible for the observed trace
activity. Indeed, this FF!ML mutation is conserved among
other functionally characterized fungal GH51 enzymes, while
the deletion of the 433–442 loop is unique to GH51 enzymes
from Aspergillus, which are the only known fungal GH51
enzyme with this trace activity (Koutaniemi & Tenkanen,
2016). A broader examination of sequence conservation
among 100 fungal GH51 enzymes using ConSurf (Ashkenazy
et al., 2016) shows that the amino-acid residues forming the
active site and core fold of the protein are highly conserved,
but that there is significantly higher variability in the loops
above and below the active-site cleft (Supplementary Fig. S7),
as well as in the inserted N-terminal domain, suggesting that
while the core function of this family is conserved, there is
significant diversity in how it recognizes and tolerates poly-
saccharide substrates.
In summary, we have presented the structure ofMgGH51, a
fungal GH51 -l-arabinofuranosidase, which was solved using
sulfur SAD data collected on the long-wavelength in vacuo
beamline I23 at Diamond Light Source. We have shown that
despite poor overall sequence conservation and the insertion
of an additional domain of as yet unknown function,MgGH51
shares a conserved active-site architecture with bacterial
homologues. We show that the active-site cleft of MgGH51
shares other key features with bacterial homologues, such as
the hydrophobic clamp in the +1 subsite, and that it lacks a
pocket which could facilitate the recognition of disubstituted
substrates, explaining its observed specificity. Through
sequence analysis and homology modelling, we have shown
that fungal GH51 enzymes display significant sequence
diversity concentrated in the loops above and below the
active-site cleft, offering a molecular basis for the observed
differences in substrate specificity reported for these essential
biomass-degrading enzymes.
4. Related literature
The following reference is cited in the supporting information
for this article: Robert & Gouet (2014).
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Lowe, E. C., Baslé, A., Morland, C., Day, A. M., Zheng, H., Rogers,
T. E., Thompson, P., Hawkins, A. R., Yadav, M. P., Henrissat, B.,
Martens, E. C., Dupree, P., Gilbert, H. J. & Bolam, D. N. (2015).
Nat. Commun. 6, 7481.
Rose, J. P., Wang, B.-C. & Weiss, M. S. (2015). IUCrJ, 2, 431–440.
Sakamoto, T., Inui, M., Yasui, K., Hosokawa, S. & Ihara, H. (2013).
Appl. Microbiol. Biotechnol. 97, 1121–1130.
Sakamoto, T. & Kawasaki, H. (2003). Biochim. Biophys. Acta, 1621,
204–210.
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